Evidence map›Paper›PMID 30974856›Full record

ArticleToxins2019

Assessment of Toxic Effects of Ochratoxin A in Human Embryonic Stem Cells.

Slaven Erceg, Eva María Mateo, Iván Zipancic, Francisco Javier Rodríguez Jiménez, María Amparo Pérez Aragó, Misericordia Jiménez, José Miguel Soria, Mª Ángeles Garcia-Esparza

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Genomic Impacts of Biological Exposures.Journal of developmental biology · 2026
    Review
  3. Toxico-pathological investigations ofJournal of advanced veterinary and animal research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Toxicological and Medical Aspects ofFrontiers in microbiology · 2019
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Slaven ErcegStem Cells Therapies in Neurodegenerative Diseases Lab, Research Center "Principe Felipe", Valencia 46012, Spain. serceg@cipf.es.
Eva María MateoDepartment of Microbiology and Ecology, University of Valencia, Valencia 46100, Spain. eva.mateo@uv.es.
Iván ZipancicDepartment of Biomedical Sciences, School of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia 46115, Spain. ivan.zipancic@uchceu.es.
Francisco Javier Rodríguez JiménezStem Cells Therapies in Neurodegenerative Diseases Lab, Research Center "Principe Felipe", Valencia 46012, Spain. frodriguez@cipf.es.
María Amparo Pérez AragóStem Cells Therapies in Neurodegenerative Diseases Lab, Research Center "Principe Felipe", Valencia 46012, Spain. mparago@cipf.es.
Misericordia JiménezDepartment of Microbiology and Ecology, University of Valencia, Valencia 46100, Spain. misericordia.jimenez@uv.es.
José Miguel SoriaDepartment of Biomedical Sciences, School of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Elche, Alicante 03204, Spain. Jose.soria@uchceu.es.
Mª Ángeles Garcia-EsparzaDepartment of Pharmacy, School of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities. Elche, Alicante 03204, Spain. maria.garcia2@uchceu.es.
Centro de Investigacion Principe Felipe · ESUniversidad Cardenal Herrera CEU · ESUniversitat de València · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España AGL2014-53928-C2-1-RUniversidad CEU Cardenal Herrera. Programa de investigación : Ayudas a la consolidación de indicadores INDI. 18/17Universidad CEU Cardenal Herrera. Programa de investigación : Ayudas a la consolidación de indicadores INDI. 18/43
6 · The paper itself

Abstract

Ochratoxin A (OTA) is a mycotoxin produced by different

Indexed as

BlastocystCell AdhesionCell ProliferationCells, CulturedCell SurvivalFood ContaminationHuman Embryonic Stem CellsHumansModels, BiologicalOchratoxinsOxidative StressTeratogensochratoxin AOchratoxinsTeratogenscell culturecellscytotoxicityhuman Stem CellsmycotoxinsOchratoxin A (OTA)

Identifiers

PMID30974856
PMCPMC6521021
OpenAlexW2938562698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.